
FDA grants expanded labelling approval of Boston Scientific’s PFA system
The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse pulsed field ablation (PFA) system. The approval marks a development in the treatment of drug-refractory, symptomatic …